1. Home
  2. OVID vs THCH Comparison

OVID vs THCH Comparison

Compare OVID & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • THCH
  • Stock Information
  • Founded
  • OVID 2014
  • THCH 2018
  • Country
  • OVID United States
  • THCH China
  • Employees
  • OVID N/A
  • THCH N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • THCH Blank Checks
  • Sector
  • OVID Health Care
  • THCH Finance
  • Exchange
  • OVID Nasdaq
  • THCH Nasdaq
  • Market Cap
  • OVID 88.9M
  • THCH 84.2M
  • IPO Year
  • OVID 2017
  • THCH N/A
  • Fundamental
  • Price
  • OVID $1.72
  • THCH $2.62
  • Analyst Decision
  • OVID Strong Buy
  • THCH
  • Analyst Count
  • OVID 4
  • THCH 0
  • Target Price
  • OVID $3.13
  • THCH N/A
  • AVG Volume (30 Days)
  • OVID 5.1M
  • THCH 14.4K
  • Earning Date
  • OVID 11-11-2025
  • THCH 11-11-2025
  • Dividend Yield
  • OVID N/A
  • THCH N/A
  • EPS Growth
  • OVID N/A
  • THCH N/A
  • EPS
  • OVID N/A
  • THCH N/A
  • Revenue
  • OVID $6,651,000.00
  • THCH $187,316,342.00
  • Revenue This Year
  • OVID $1,086.57
  • THCH N/A
  • Revenue Next Year
  • OVID N/A
  • THCH N/A
  • P/E Ratio
  • OVID N/A
  • THCH N/A
  • Revenue Growth
  • OVID 1070.95
  • THCH N/A
  • 52 Week Low
  • OVID $0.24
  • THCH $1.95
  • 52 Week High
  • OVID $2.01
  • THCH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • OVID 63.50
  • THCH 49.97
  • Support Level
  • OVID $1.24
  • THCH $2.50
  • Resistance Level
  • OVID $2.01
  • THCH $2.74
  • Average True Range (ATR)
  • OVID 0.20
  • THCH 0.09
  • MACD
  • OVID 0.03
  • THCH 0.01
  • Stochastic Oscillator
  • OVID 66.29
  • THCH 48.00

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About THCH TH International Limited Ordinary shares

TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.

Share on Social Networks: